Get the Stockscreener App
1.21
3.20%
-0.04
After Hours:
1.22
0.01
+0.83%
Outlook Therapeutics Inc Stock (OTLK) Forecast
The Outlook Therapeutics Inc (OTLK) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $16.04, representing a +1,226% increase from the current price of $1.21. The highest analyst price target is $16.37, and the lowest is $15.71.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month OTLK Price Target
Average 21.34
(+1,664% Upside)
Is Outlook Therapeutics Inc (OTLK) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 34.51 | Neutral |
| STOCH(9,6) | 23.85 | Neutral |
| STOCHRSI(14) | 9.3725 | Buy |
| MACD(12,26) | -0.1051 | Sell |
| ADX(14) | 33.54 | Sell |
| William %R | -84.71 | Buy |
| CCI(14) | -114.47 | Sell |
Buy: 2
Sell: 3
Neutral: 2
Summary: Sell
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.3315
Sell
|
1.311
Sell
|
| MA20 |
1.4143
Sell
|
1.3909
Sell
|
| MA50 |
1.5957
Sell
|
1.6733
Sell
|
| MA100 |
2.247
Sell
|
2.4606
Sell
|
| MA200 |
4.5353
Sell
|
3.9293
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, OTLK could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 13 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on OTLK, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 34.51 indicates that OTLK is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 23.85 indicates that OTLK is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 9.3725 indicates that OTLK is oversold. This suggests that OTLK price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 33.54 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -114.47 indicates that OTLK is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term OTLK price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Outlook Therapeutics Inc financial reports and earnings history, Outlook Therapeutics Inc (OTLK) stock could reach $18.76 by 2030, $128.20 by 2040 and $163.99 by 2050. See the projected annual prices until 2050 of the Outlook Therapeutics Inc stock below:
- Outlook Therapeutics Inc (OTLK) is expected to reach an average price of $95.42 in 2035, with a high prediction of $95.42 and a low estimate of $94.24. This indicates an $7,786% rise from the last recorded price of $1.21.
- Outlook Therapeutics Inc (OTLK) stock is projected to chart a bullish course in 2040, with an average price target of $128.08, representing an $10,485% surge from its current level. The forecast ranges from a conservative $126.67 to a sky-high $128.20.
- Our analysts predict Outlook Therapeutics Inc (OTLK) to jump 12,354% by 2045, soaring from $148.73 to an average price of $150.69, potentially reaching $150.77. While $148.73 is the low estimate, the potential upside is significant.
- Outlook Therapeutics Inc (OTLK) stock is expected to climb by 2050, reaching an average of $163.88, a $13,444% jump from its current level. However, a wide range of estimates exists, with high and low targets of $163.99 and $161.20, respectively, highlighting the market's uncertainty.
Outlook Therapeutics Inc Stock (OTLK) Year by Year Forecast
Outlook Therapeutics Inc Stock (OTLK) Price Forecast for 2025
Outlook Therapeutics Inc Stock (OTLK) is expected to reach an average price of $17.20 in 2025, with a high prediction of $21.14 and a low estimate of $13.26. This indicates an +1,321% rise from the last recorded price of $1.21.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2025 | $16.28 | $15.71 | $16.37 | +1,245% |
| June, 2025 | $16.93 | $16.42 | $17.06 | +1,299% |
| July, 2025 | $18.32 | $17.06 | $18.56 | +1,414% |
| August, 2025 | $18.99 | $18.34 | $19.04 | +1,470% |
| September, 2025 | $19.47 | $19.04 | $19.60 | +1,509% |
| October, 2025 | $19.58 | $19.28 | $20.07 | +1,518% |
| November, 2025 | $20.25 | $19.69 | $20.27 | +1,574% |
| December, 2025 | $21.07 | $20.37 | $21.14 | +1,641% |
Outlook Therapeutics Inc Stock (OTLK) Price Forecast for 2026
The predicted value for Outlook Therapeutics Inc (OTLK) in 2026 is set at an average of $25.84. Estimates vary from a peak of $30.49 to a trough of $21.18, indicating an +2,035% surge from the present price of $1.21.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $22.12 | $21.18 | $22.20 | +1,728% |
| February, 2026 | $22.93 | $22.19 | $22.95 | +1,795% |
| March, 2026 | $23.32 | $23.01 | $23.40 | +1,828% |
| April, 2026 | $25.29 | $23.34 | $26.97 | +1,990% |
| May, 2026 | $25.93 | $24.76 | $25.94 | +2,043% |
| June, 2026 | $26.26 | $25.53 | $26.41 | +2,070% |
| July, 2026 | $26.91 | $25.97 | $27.09 | +2,124% |
| August, 2026 | $28.03 | $26.98 | $28.14 | +2,216% |
| September, 2026 | $28.80 | $27.93 | $28.82 | +2,280% |
| October, 2026 | $29.28 | $28.54 | $30.06 | +2,320% |
| November, 2026 | $30.15 | $29.17 | $30.25 | +2,392% |
| December, 2026 | $30.31 | $30.11 | $30.49 | +2,405% |
Outlook Therapeutics Inc Stock (OTLK) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Outlook Therapeutics Inc (OTLK) is $33.84, with a high forecast of $37.27 and a low forecast of $30.41. This indicates an +2,696% increase from the last price of $1.21.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $30.87 | $30.41 | $30.93 | +2,451% |
| February, 2027 | $30.89 | $30.88 | $31.45 | +2,453% |
| March, 2027 | $31.56 | $30.69 | $31.63 | +2,508% |
| April, 2027 | $32.04 | $31.59 | $32.06 | +2,548% |
| May, 2027 | $32.64 | $32.08 | $32.86 | +2,597% |
| June, 2027 | $33.80 | $32.77 | $33.95 | +2,694% |
| July, 2027 | $34.46 | $33.94 | $34.79 | +2,748% |
| August, 2027 | $34.97 | $34.60 | $35.12 | +2,790% |
| September, 2027 | $35.73 | $34.93 | $35.74 | +2,853% |
| October, 2027 | $35.64 | $34.87 | $35.71 | +2,845% |
| November, 2027 | $36.48 | $35.75 | $36.48 | +2,915% |
| December, 2027 | $37.20 | $36.49 | $37.27 | +2,974% |
Outlook Therapeutics Inc Stock (OTLK) Price Forecast for 2028
In 2028, Outlook Therapeutics Inc (OTLK) is projected to reach an average price of $41.45, with a high projection of $45.60 and a low estimate of $37.30. This indicates an +3,326% rise from the last price of $1.21.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $37.69 | $37.30 | $37.73 | +3,015% |
| February, 2028 | $38.43 | $37.83 | $38.51 | +3,076% |
| March, 2028 | $39.12 | $38.57 | $39.21 | +3,133% |
| April, 2028 | $39.62 | $39.12 | $39.65 | +3,174% |
| May, 2028 | $40.39 | $39.72 | $40.42 | +3,238% |
| June, 2028 | $41.02 | $40.45 | $41.30 | +3,290% |
| July, 2028 | $41.78 | $41.16 | $41.83 | +3,353% |
| August, 2028 | $42.30 | $41.76 | $42.46 | +3,396% |
| September, 2028 | $42.92 | $42.43 | $43.01 | +3,447% |
| October, 2028 | $43.64 | $43.04 | $43.69 | +3,507% |
| November, 2028 | $44.85 | $43.77 | $44.91 | +3,607% |
| December, 2028 | $45.59 | $44.97 | $45.60 | +3,668% |
Outlook Therapeutics Inc Stock (OTLK) Price Forecast for 2029
The 2029 price forecast for Outlook Therapeutics Inc Stock (OTLK) is $39.72 on average, with a high prediction of $63.65 and a low estimate of $15.78. This represents an +3,182% increase from the previous price of $1.21.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $46.34 | $45.61 | $46.35 | +3,730% |
| February, 2029 | $46.37 | $46.34 | $46.66 | +3,732% |
| March, 2029 | $46.03 | $45.57 | $46.82 | +3,704% |
| April, 2029 | $46.75 | $46.17 | $46.78 | +3,763% |
| May, 2029 | $47.58 | $46.88 | $47.71 | +3,832% |
| June, 2029 | $48.25 | $47.72 | $48.26 | +3,888% |
| July, 2029 | $48.78 | $48.32 | $48.89 | +3,931% |
| August, 2029 | $49.53 | $48.91 | $49.59 | +3,993% |
| September, 2029 | $50.18 | $49.64 | $50.23 | +4,047% |
| October, 2029 | $59.13 | $50.33 | $62.22 | +4,787% |
| November, 2029 | $59.27 | $58.35 | $63.65 | +4,799% |
| December, 2029 | $15.80 | $15.78 | $60.70 | +1,206% |
Outlook Therapeutics Inc Stock (OTLK) Price Forecast for 2030
Outlook Therapeutics Inc Stock (OTLK) is expected to reach an average price of $23.34 in 2030, with a high forecast of $30.93 and a low forecast of $15.75. This signifies an +1,829% surge from the last price of $1.21.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $18.43 | $15.75 | $18.76 | +1,423% |
| February, 2030 | $19.43 | $18.34 | $19.68 | +1,506% |
| March, 2030 | $20.69 | $19.53 | $20.87 | +1,610% |
| April, 2030 | $21.27 | $20.85 | $21.59 | +1,657% |
| May, 2030 | $22.74 | $21.39 | $22.75 | +1,779% |
| June, 2030 | $23.69 | $22.90 | $23.78 | +1,858% |
| July, 2030 | $25.03 | $23.93 | $25.11 | +1,968% |
| August, 2030 | $26.32 | $25.22 | $26.44 | +2,075% |
| September, 2030 | $27.29 | $26.00 | $27.51 | +2,155% |
| October, 2030 | $28.83 | $27.53 | $28.97 | +2,283% |
| November, 2030 | $29.75 | $29.09 | $29.85 | +2,359% |
| December, 2030 | $30.89 | $29.90 | $30.93 | +2,453% |
1.23%
1.63%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):